Try our business solution for free!

Leading U.S. pharmaceutical products by revenue 2026

Published by
Matej Mikulic,
Aug 27, 2021
Bristol-Myers Squibb's Eliquis and Opdivo are expected to have a place among the top 10 U.S. drugs in 2026, generating some 7.8 billion and 6.1 billion U.S. dollars in revenues, respectively. This statistic displays a projection of the top 10 pharmaceutical products in the United States by revenue in 2026.

Projected top 10 pharmaceutical products by U.S. revenue in 2026 (in million U.S. dollars)

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2020

Region

United States

Survey time period

as of June 2020

Supplementary notes

Values represent company reported sales when available, otherwise based on average of equity analyst estimates.

Open this statistic in...
Spanish
Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Top pharmaceutical drugs "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Top pharmaceutical drugs

Global overview

4

Top companies' top products

5

Best-selling drugs

8

U.S. overview

4

Outlook

5

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in the U.S.Global pharmaceutical industryBiotech drugsTop pharmaceutical drugsPharmaceutical industry in the UK
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu